Immunogen Inc (DELISTED) (IMGN:DL)
31.23
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
Immunogen Debt to Equity Ratio: 0.1284 for Sept. 30, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2023 | 0.1284 |
| June 30, 2023 | 0.1466 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.0161 |
| March 31, 2021 | 0.0223 |
| December 31, 2020 | 0.0234 |
| September 30, 2020 | -0.0487 |
| June 30, 2020 | -0.085 |
| March 31, 2020 | -0.5074 |
| December 31, 2019 | -0.0273 |
| September 30, 2019 | -0.0241 |
| June 30, 2019 | -0.0304 |
| March 31, 2019 | -0.0749 |
| December 31, 2018 | 0.1881 |
| September 30, 2018 | 0.0439 |
| June 30, 2018 | 0.0231 |
| March 31, 2018 | -0.0565 |
| December 31, 2017 | -0.1146 |
| September 30, 2017 | -0.0272 |
| Date | Value |
|---|---|
| June 30, 2017 | -0.5617 |
| March 31, 2017 | -0.5798 |
| September 30, 2016 | -0.7899 |
| June 30, 2016 | -1.174 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
| March 31, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.5074
Minimum
Mar 2020
0.1466
Maximum
Jun 2023
-0.0215
Average
--
Median
Sep 2021
Debt to Equity Ratio Benchmarks
| AbbVie Inc | 5.732 |
| Pfizer Inc | 0.7959 |
| Johnson & Johnson | 0.4803 |
| Merck & Co Inc | 0.9328 |
| Cerevel Therapeutics Holdings Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 822.10M |
| Total Liabilities (Quarterly) | 260.50M |
| Shareholders Equity (Quarterly) | 561.60M |
| Current Ratio | 5.695 |
| Net Debt Paydown Yield | -0.34% |